✦ LIBER ✦

Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer

✍ Scribed by Minoru Fukuda, Yoichi Nakamura, Akitoshi Kinoshita…

Book ID: 120776517
Publisher: Springer
Year: 2012
Tongue: English
Weight: 303 KB
Volume: 70
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-1952-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of irinotecan and cisplati

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small-cell lung cancer

✍ M Oka; M Fukuda; M Kuba; M Ichiki; T Rikimaru; H Soda; J Tsurutani; Y Nakamura; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Phase II trial of irinotecan and cisplat

Phase II trial of irinotecan and cisplatin with early concurrent radiotherapy in limited-disease small-cell lung cancer

✍ Joo Hyuk Sohn; Yong Wha Moon; Chang Geol Lee; Gwi Eon Kim; Kyung Young Chung; Jo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## BACKGROUND. A Phase II trial of irinotecan and cisplatin (IP) with early concurrent radiotherapy was performed in limited‐disease small‐cell lung cancer (LD‐SCLC) to evaluate the efficacy and toxicity. ## METHODS. For untreated LD‐SCLC patients, irinotecan (60 mg/m^2^, Days 1, 8,

Phase II study of irinotecan plus cispla

Phase II study of irinotecan plus cisplatin with concurrent radiotherapy for the patients with limited-disease small-cell lung cancer

✍ Jeong, Hye Cheol; Lee, Sang Yeub; Lee, Sung Yong; Kim, Je Hyeong; Shin, Chol; Sh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 155 KB

P-776 Phase II trial of irinotecan and c

P-776 Phase II trial of irinotecan and cisplatin with concurrent radiotherapy in limited-disease small cell lung cancer

✍ Kim, J.; Moon, Y.; Sohn, J. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Phase I study of irinotecan and cisplati

Phase I study of irinotecan and cisplatin with concurrent split-course radiotherapy in unresectable and locally advanced non-small cell lung cancer

✍ M Oka; M Fukuda; M Fukuda; A Kinoshita; M Kuba; M Ichiki; T Rikimaru; H Soda; H 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Irinotecan and cisplatin with concurrent

Irinotecan and cisplatin with concurrent split-course radiotherapy in locally advanced nonsmall-cell lung cancer : A multiinstitutional phase 2 study

✍ Minoru Fukuda; Hiroshi Soda; Masaaki Fukuda; Akitoshi Kinoshita; Yoichi Nakamura 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views

## Abstract ## BACKGROUND. The purpose was to determine the efficacy and toxicity of irinotecan and cisplatin with concurrent split‐course thoracic radiotherapy (TRT) in locally advanced nonsmall‐cell lung cancer. ## METHODS. Fifty patients fulfilling the following eligibility criteria were enro